Compare Dover Corp (DOV) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dover Corp vs HCA Health Inc — how do they compare? Dover Corp trades at $190.16 (market cap $25.36B), while HCA Health Inc trades at $443.69 (market cap $95.08B). The key difference: HCA Health Inc is far larger — about 3.7× Dover Corp's market cap, and Dover Corp pays the higher dividend (1.12%). Which is the better fit depends on your goals — on Pluang, investors hold Dover Corp for 73 Days and HCA Health Inc for 76 Days on average.
| DOV | HCA | |
|---|---|---|
Market Cap | $25.36B | $95.08B |
Volume | 661,752 | 998,787 |
Sector | Industrials | Health |
52-Week High | $233.31 | $545.13 |
52-Week Low | $161.16 | $361.32 |
Typical Hold Time | 73 Days | 76 Days |
Enterprise Value | $26.86B | $145.62B |
Dividend Yield | 1.12% | 0.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOV trades at $188.96, down 1.52% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company maintains strong profitability with a net income margin of 13.48% and has beaten earnings estimates for three consecutive quarters. Recent news highlights product launches and strategic acquisitions, including the completion of the Cloeren acquisition in August 2026, supporting growth initiatives.
Analyst consensus is strongly bullish with a $243.20 price target, implying significant upside. Key risks include execution of acquisitions and macroeconomic pressures on industrial demand. The stock's valuation multiples appear reasonable relative to earnings growth, positioning it for potential recovery if operational momentum continues.
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
